statistiche ricercatore

Continente	#
NA - Nord America	467
AS - Asia	243
EU - Europa	224
SA - Sud America	28
Continente sconosciuto - Info sul continente non disponibili	27
AF - Africa	6
OC - Oceania	1
Totale	996

Nazione	#
US - Stati Uniti d'America	450
SG - Singapore	99
IT - Italia	86
CN - Cina	42
VN - Vietnam	37
BD - Bangladesh	31
DE - Germania	31
IE - Irlanda	26
RU - Federazione Russa	24
BR - Brasile	20
SE - Svezia	19
HK - Hong Kong	12
CA - Canada	8
IN - India	8
FI - Finlandia	7
GB - Regno Unito	6
AT - Austria	5
ES - Italia	4
FR - Francia	4
NL - Olanda	4
PL - Polonia	4
MX - Messico	3
TR - Turchia	3
BO - Bolivia	2
DK - Danimarca	2
GP - Guadalupe	2
IQ - Iraq	2
KE - Kenya	2
MA - Marocco	2
AR - Argentina	1
AU - Australia	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
GT - Guatemala	1
ID - Indonesia	1
IL - Israele	1
JO - Giordania	1
JP - Giappone	1
KH - Cambogia	1
KZ - Kazakistan	1
NI - Nicaragua	1
NP - Nepal	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PY - Paraguay	1
SV - El Salvador	1
TN - Tunisia	1
UY - Uruguay	1
UZ - Uzbekistan	1
ZA - Sudafrica	1
Totale	970

Nome	#
Characterizing the building blocks of Problematic Use of the Internet (PUI): The role of obsessional impulses and impulsivity traits among Italian young adults	163
What role for cognitive remediation in the treatment of depressive symptoms? A superiority and noninferiority meta-analysis for clinicians	134
Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in Italy	117
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults	109
Craving variations in patients with substance use disorder and gambling during COVID-19 lockdown: The Italian experience	108
Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial	104
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review	103
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial	89
Online 12-step groups during the Covid-19 pandemic: A patient's perspective	69
Totale	996

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	14	0	0	0	0	0	0	2	2	4	0	2	4
2022/2023	100	5	12	4	5	11	24	5	10	20	0	1	3
2023/2024	84	4	3	17	2	4	28	6	1	4	3	4	8
2024/2025	183	19	25	15	6	3	14	10	8	12	19	29	23
2025/2026	478	33	20	29	59	53	27	63	31	51	30	60	22
2026/2027	101	6	18	28	29	20	0	0	0	0	0	0	0
Totale													996